Estimating The Burden Of Group A Streptococcal Diseases In Victoria
Funder
National Health and Medical Research Council
Funding Amount
$386,760.00
Summary
Despite the considerable advances in the diagnosis and treatment of group A streptococcal (GAS) diseases made during the last century, the impressive spectrum of infections caused by this organism continues to have a significant impact in developed countries. This spectrum includes diseases that are mild but common (e.g. sore throat, skin sores), rare but very severe (e.g. bloodstream infections, flesh-eating bacteria) and those that are more common in developing countries and the Aboriginal pop ....Despite the considerable advances in the diagnosis and treatment of group A streptococcal (GAS) diseases made during the last century, the impressive spectrum of infections caused by this organism continues to have a significant impact in developed countries. This spectrum includes diseases that are mild but common (e.g. sore throat, skin sores), rare but very severe (e.g. bloodstream infections, flesh-eating bacteria) and those that are more common in developing countries and the Aboriginal population (e.g. rheumatic fever, kidney disease). Streptococcal sore throat remains one of the most common childhood infections, and severe group A streptococcal diseases are thought to be increasing in incidence in Australia. Yet, there are no accurate data on the incidence and costs of these or other GAS diseases in non-Aboriginal Australians, or in most other populations around the world. It is becoming more urgent to collect this data as numerous vaccine candidates are entering human trials, new approaches to the treatment of sore throat are emerging, and new strategies to treat and control the spread of severe disease are being developed. We propose a comprehensive strategy to measure the incidence, prevalence and costs of each group of GAS diseases. We will follow a group of families for 12 months to detect cases of GAS sore throat and skin sores and measure the impact on the family. We will survey children in schools to estimate the prevalence of skin sores. We will check hospital records to calculate the number of cases of rheumatic fever and kidney disease. And we will maintain surveillance for severe diseases by checking hospital and laboratory records. We will also check to see if family members of people with severe disease have the GAS bacterium in their throats. We will then compile these data into a comprehensive estimate of the burden of disease in Victoria, and estimate the cost-effectiveness of different treatment and prevention strategies.Read moreRead less
Characterisation Of Anti-HBs Responses In Patients Undergoing Functional Hepatitis B Cure: Implication For Future Therapies
Funder
National Health and Medical Research Council
Funding Amount
$723,649.00
Summary
The hepatitis B virus causes liver cirrhosis and liver cancer. There is no cure for hepatitis B. However, a small number of patients can naturally rid themselves of the virus. We have identified 14 of these individuals and discovered that they have a unique immune response that is responsible for these “natural” cures. We plan to characterise this immune response and turn it into a therapeutic vaccine which can be used to cure patients who are still chronically infected.
Investigating The Host Determinants Of Viral Clearance Versus Collateral Pathology In Chronic Infection
Funder
National Health and Medical Research Council
Funding Amount
$1,250,756.00
Summary
Hepatitis B virus has infected over 2 billion people. Some people control the virus but it remains incurable and there is a lifelong risk of liver cancer. Understanding how host cells interact with the virus, the mechanisms the cells use in an attempt to eliminate the virus and the mechanisms the virus uses to sabotage these responses, will provide insights that could lead to therapies. Potential therapies could be applicable to other infections like HIV-1 and tuberculosis.
Determinants Of Sustained Virological Response After Discontinuation Of Long-term Nucleoside Analogue Therapy In Chronic Hepatitis B Patients
Funder
National Health and Medical Research Council
Funding Amount
$976,778.00
Summary
Guidelines currently recommend lifelong treatment for patients with chronic hepatitis B, with associated cost and risks of drug resistance and side effects. It has recently been suggested that up to 50% of patients may safely and successfully stop drug after long-term treatment. Our project will identify which patients can safely stop treatment, by performing detailed studies of the human immune system and the hepatitis B virus. This will be an important advance for patient care.
How Do Cross-reactive Memory B Cells Affect Influenza Vaccine Titers?
Funder
National Health and Medical Research Council
Funding Amount
$798,049.00
Summary
Influenza vaccines are updated frequently to protect against the highly variable influenza virus. Despite careful selection of vaccine viruses, most influenza vaccines provide only modest protection and protection is poor some years. In turn, the response to vaccination varies between individuals. This probably reflects complex and variable histories of influenza infection and vaccination. The project investigates how past influenza exposure influences vaccine responses and effectiveness.
New Drug Combinations To Enhance Elimination Of Hepatitis B Infection
Funder
National Health and Medical Research Council
Funding Amount
$888,304.00
Summary
We have developed a therapy that kills hepatitis B virus infected cells and promotes elimination of infection. We are now testing novel drugs that can be used to maximise the efficacy of our new treatment to promote better outcomes that may be translated to other infections.
Long Term Persistence Of HIV In The Liver And The Clinical Impact On HIV-HBV Co-infection
Funder
National Health and Medical Research Council
Funding Amount
$1,393,245.00
Summary
This grant will address a major question in HIV cure research - the role of the liver as an HIV reservoir and the impact of HIV persistence in HIV-infected patients on suppressive antiretroviral therapy (ART) on liver disease, in the setting of HIV-HBV co-infection. We will trial a novel intervention to reduce HIV infection of the liver that could potentially reduce chronic liver disease in this setting.
Computing with Lie groups and algebras: nilpotent orbits and applications. This project aims to advance knowledge of an important class of Lie algebras, for which recent work has shown that a deeper mathematical theory, and better computational tools are required. Lie theory is a mathematical area with rich applications in the physical sciences. Expected outcomes from this project include the first systematic treatment of these algebras, new powerful algorithms to compute with them, and explicit ....Computing with Lie groups and algebras: nilpotent orbits and applications. This project aims to advance knowledge of an important class of Lie algebras, for which recent work has shown that a deeper mathematical theory, and better computational tools are required. Lie theory is a mathematical area with rich applications in the physical sciences. Expected outcomes from this project include the first systematic treatment of these algebras, new powerful algorithms to compute with them, and explicit nilpotent orbit classifications that will solve open problems in black hole theory. This should significantly enhance fundamental mathematical research and the Lie functionality of leading computer algebra systems, and is expected to strengthen international linkages.Read moreRead less
Advancing the Metal-Organic Chemistry of the Heavy Alkaline Earth Elements. The project will open up a new area in Australian metal based chemical research, deriving high value added products from the already existing exploitation of Australia's substantial alkaline earth metal mineral resources. Internationally recognised expertise in the design and manipulation of highly reactive chemical tools will contribute breakthrough science and innovation to the growing pharmaceutical, fine chemicals an ....Advancing the Metal-Organic Chemistry of the Heavy Alkaline Earth Elements. The project will open up a new area in Australian metal based chemical research, deriving high value added products from the already existing exploitation of Australia's substantial alkaline earth metal mineral resources. Internationally recognised expertise in the design and manipulation of highly reactive chemical tools will contribute breakthrough science and innovation to the growing pharmaceutical, fine chemicals and smart materials industry, with the potential to provide nascent and established Australian companies a competitive edge in new product development. Students will be trained in the necessary skills to succeed in and expand such technically demanding area of metal based chemistry.Read moreRead less
Frontiers in synthetic and structural rare earth chemistry. Rare earth elements are a major under-utilised Auatralian resource.
Their commercial development requires knowledge and progression of their
chemistry. Advancing the chemistry of highly reactive, air-sensitive
metalorganics will provide the breakthrough science to underpin future
applications in chemical manufacture, catalysis and new materials.
Transformation of rare earth chemistry to achieve behaviour hitherto
atypical of these ....Frontiers in synthetic and structural rare earth chemistry. Rare earth elements are a major under-utilised Auatralian resource.
Their commercial development requires knowledge and progression of their
chemistry. Advancing the chemistry of highly reactive, air-sensitive
metalorganics will provide the breakthrough science to underpin future
applications in chemical manufacture, catalysis and new materials.
Transformation of rare earth chemistry to achieve behaviour hitherto
atypical of these elements by steric and electronic modulation of
attached groups will value-add to their properties.Read moreRead less